These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22728550)

  • 21. Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
    Pellagatti A; Boultwood J
    Adv Biol Regul; 2017 Jan; 63():59-70. PubMed ID: 27639445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Charting the "Splice" Routes to MDS.
    Obeng EA; Ebert BL
    Cancer Cell; 2015 May; 27(5):607-9. PubMed ID: 25965565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splicing factor mutations in myelodysplasia.
    Ogawa S
    Int J Hematol; 2012 Oct; 96(4):438-42. PubMed ID: 23054646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The SF3b155 N-terminal domain is a scaffold important for splicing.
    Cass DM; Berglund JA
    Biochemistry; 2006 Aug; 45(33):10092-101. PubMed ID: 16906767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.
    Shirai CL; Ley JN; White BS; Kim S; Tibbitts J; Shao J; Ndonwi M; Wadugu B; Duncavage EJ; Okeyo-Owuor T; Liu T; Griffith M; McGrath S; Magrini V; Fulton RS; Fronick C; O'Laughlin M; Graubert TA; Walter MJ
    Cancer Cell; 2015 May; 27(5):631-43. PubMed ID: 25965570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.
    Sallman DA; Komrokji R; Vaupel C; Cluzeau T; Geyer SM; McGraw KL; Al Ali NH; Lancet J; McGinniss MJ; Nahas S; Smith AE; Kulasekararaj A; Mufti G; List A; Hall J; Padron E
    Leukemia; 2016 Mar; 30(3):666-73. PubMed ID: 26514544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast.
    Carrocci TJ; Zoerner DM; Paulson JC; Hoskins AA
    Nucleic Acids Res; 2017 May; 45(8):4837-4852. PubMed ID: 28062854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent pathway mutations of splicing machinery in myelodysplasia.
    Yoshida K; Sanada M; Shiraishi Y; Nowak D; Nagata Y; Yamamoto R; Sato Y; Sato-Otsubo A; Kon A; Nagasaki M; Chalkidis G; Suzuki Y; Shiosaka M; Kawahata R; Yamaguchi T; Otsu M; Obara N; Sakata-Yanagimoto M; Ishiyama K; Mori H; Nolte F; Hofmann WK; Miyawaki S; Sugano S; Haferlach C; Koeffler HP; Shih LY; Haferlach T; Chiba S; Nakauchi H; Miyano S; Ogawa S
    Nature; 2011 Sep; 478(7367):64-9. PubMed ID: 21909114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of mast cell disease.
    Soucie E; Brenet F; Dubreuil P
    Mol Immunol; 2015 Jan; 63(1):55-60. PubMed ID: 24768320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms.
    Brierley CK; Steensma DP
    Curr Hematol Malig Rep; 2016 Dec; 11(6):408-415. PubMed ID: 27492253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SRSF2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA Splicing.
    Komeno Y; Huang YJ; Qiu J; Lin L; Xu Y; Zhou Y; Chen L; Monterroza DD; Li H; DeKelver RC; Yan M; Fu XD; Zhang DE
    Mol Cell Biol; 2015 Sep; 35(17):3071-82. PubMed ID: 26124281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies.
    Taylor J; Lee SC
    Genes Chromosomes Cancer; 2019 Dec; 58(12):889-902. PubMed ID: 31334570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Splicing up the classification of myelodysplasia.
    Radich J
    Blood; 2015 Jul; 126(2):128-9. PubMed ID: 26160185
    [No Abstract]   [Full Text] [Related]  

  • 34. A common alternative splicing signature is associated with SF3B1 mutations in malignancies from different cell lineages.
    Gentien D; Kosmider O; Nguyen-Khac F; Albaud B; Rapinat A; Dumont AG; Damm F; Popova T; Marais R; Fontenay M; Roman-Roman S; Bernard OA; Stern MH
    Leukemia; 2014 Jun; 28(6):1355-7. PubMed ID: 24434863
    [No Abstract]   [Full Text] [Related]  

  • 35. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
    Graubert TA; Shen D; Ding L; Okeyo-Owuor T; Lunn CL; Shao J; Krysiak K; Harris CC; Koboldt DC; Larson DE; McLellan MD; Dooling DJ; Abbott RM; Fulton RS; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Grillot M; Baty J; Heath S; Frater JL; Nasim T; Link DC; Tomasson MH; Westervelt P; DiPersio JF; Mardis ER; Ley TJ; Wilson RK; Walter MJ
    Nat Genet; 2011 Dec; 44(1):53-7. PubMed ID: 22158538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
    Scott LM; Rebel VI
    J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.
    Kim E; Ilagan JO; Liang Y; Daubner GM; Lee SC; Ramakrishnan A; Li Y; Chung YR; Micol JB; Murphy ME; Cho H; Kim MK; Zebari AS; Aumann S; Park CY; Buonamici S; Smith PG; Deeg HJ; Lobry C; Aifantis I; Modis Y; Allain FH; Halene S; Bradley RK; Abdel-Wahab O
    Cancer Cell; 2015 May; 27(5):617-30. PubMed ID: 25965569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of the regulatory mechanism for the constitutive splicing using molecular genetics in fission yeast].
    Haraguchi N; Tani T
    Tanpakushitsu Kakusan Koso; 2009 Dec; 54(16 Suppl):2038-43. PubMed ID: 21089614
    [No Abstract]   [Full Text] [Related]  

  • 39. Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators.
    Qiu J; Zhou B; Thol F; Zhou Y; Chen L; Shao C; DeBoever C; Hou J; Li H; Chaturvedi A; Ganser A; Bejar R; Zhang DE; Fu XD; Heuser M
    RNA; 2016 Oct; 22(10):1535-49. PubMed ID: 27492256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis.
    McKerrell T; Park N; Moreno T; Grove CS; Ponstingl H; Stephens J; ; Crawley C; Craig J; Scott MA; Hodkinson C; Baxter J; Rad R; Forsyth DR; Quail MA; Zeggini E; Ouwehand W; Varela I; Vassiliou GS
    Cell Rep; 2015 Mar; 10(8):1239-45. PubMed ID: 25732814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.